Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new concept proposed in 2020. Unlike non-alcoholic fatter liver disease (NAFLD), the diagnosis of MAFLD requires the presence any of the following 3 metabolic risks, including overweight/obesity, presence of diabetes mellitus, and evidence of metabolic dysregulation.
graso
Criteria for Diagnostic of Fat Embolism Syndrome (FES)
Fat embolism syndrome, a condition characterized by hypoxia, bilateral pulmonary infiltrates, and mental status change.
Histological Scoring System for Nonalcoholic Fatty Liver Disease (NAFLD)
Components of NAFLD Activity Score (NAS) and Fibrosis Staging